Literature DB >> 8907723

Pharmacokinetics of superoxide dismutase in rats after oral administration.

C Regnault1, M Soursac, M Roch-Arveiller, E Postaire, G Hazebroucq.   

Abstract

The kinetic behaviour of bovine erythrocyte Cu-Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0 center dot 5 to 20 mg kg-1. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The maximum concentration (Cmax) in blood cell pellets ranged from 8 center dot 65 to 11 center dot 03 U/mg haemoglobin (Hb) after subcutaneous injection, and from 4 center dot 48 to 8 center dot 23 U/mg Hb after oral administration. The maximum concentrations were reached in 5 h (t max) for the two routes. Comparison between the areas under the curves (AUCs) obtained after subcutaneous and oral administration allowed the calculation of relative bioavailability (F'). The maximum bioavailability after oral administration was 14% for free SOD, 22% for SOD encapsulated into liposomes, and 57% when ceramides were added to liposomes. Poor SOD bioavailability was enhanced by liposome encapsulation, and ceramide addition seemed to be beneficial for oral encapsulated SOD administration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8907723     DOI: 10.1002/(SICI)1099-081X(199603)17:2<165::AID-BDD945>3.0.CO;2-N

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  7 in total

1.  Kinetic evaluation of nitric oxide production in pleural exudate after induction of two inflammatory reactions in the rat.

Authors:  C Regnault; M Roch-Arveiller; I Florentin; J P Giroud; E Postaire; M Delaforge
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

2.  The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

Authors:  Gokulakrishnan Seshadri; Jay C Sy; Milton Brown; Sergey Dikalov; Stephen C Yang; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2009-11-03       Impact factor: 12.479

Review 3.  Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action.

Authors:  Julie Carillon; Jean-Max Rouanet; Jean-Paul Cristol; Richard Brion
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

4.  Subcutaneous administration of bovine superoxide dismutase protects lungs from radiation-induced lung injury.

Authors:  Vlado Antonic; Zahid N Rabbani; Isabel L Jackson; Zeljko Vujaskovic
Journal:  Free Radic Res       Date:  2015-08-11

5.  Liposomal Antioxidants for Protection against Oxidant-Induced Damage.

Authors:  Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-08-16

6.  Glucose-lowering effects of orally administered superoxide dismutase in type 2 diabetic model rats.

Authors:  Jingke Guo; Hangqi Liu; Dan Zhao; Chaoyi Pan; Xuepu Jin; Yujia Hu; Xiaolu Gao; Pingfan Rao; Shutao Liu
Journal:  NPJ Sci Food       Date:  2022-08-20

Review 7.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.